182 related articles for article (PubMed ID: 12171829)
1. Dobutamine gated blood pool scintigraphy predicts the improvement of cardiac sympathetic nerve activity, cardiac function, and symptoms after treatment in patients with dilated cardiomyopathy.
Kasama S; Toyama T; Hoshizaki H; Oshima S; Taniguchi K; Suzuki T; Kurabayashi M
Chest; 2002 Aug; 122(2):542-8. PubMed ID: 12171829
[TBL] [Abstract][Full Text] [Related]
2. [Prediction of cardiac sympathetic nerve activity and cardiac functional outcome after treatment in patients with dilated cardiomyopathy: examination using dobutamine gated blood pool scintigraphy].
Kasama S; Toyama T; Hoshizaki H; Oshima S; Taniguchi K; Iwasaki T; Suzuki T; Nagai R
J Cardiol; 2000 Jul; 36(1):29-35. PubMed ID: 10929263
[TBL] [Abstract][Full Text] [Related]
3. Cardiac sympathetic activity estimated by 123I-MIBG myocardial imaging in patients with dilated cardiomyopathy after beta-blocker or angiotensin-converting enzyme inhibitor therapy.
Toyama T; Aihara Y; Iwasaki T; Hasegawa A; Suzuki T; Nagai R; Endo K; Hoshizaki H; Oshima S; Taniguchi K
J Nucl Med; 1999 Feb; 40(2):217-23. PubMed ID: 10025826
[TBL] [Abstract][Full Text] [Related]
4. Dobutamine stress 99mTc-tetrofosmin quantitative gated SPECT predicts improvement of cardiac function after carvedilol treatment in patients with dilated cardiomyopathy.
Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Tange S; Suzuki T; Kurabayashi M
J Nucl Med; 2004 Nov; 45(11):1878-84. PubMed ID: 15534058
[TBL] [Abstract][Full Text] [Related]
5. Myocardial contractile reserve determined by dobutamine stress Tc-99m tetrofosmin quantitative gated SPECT predicts late spontaneous improvement in cardiac function in patients with recent-onset dilated cardiomyopathy.
Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
J Nucl Cardiol; 2003; 10(6):607-14. PubMed ID: 14668772
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol.
Kasama S; Toyama T; Hatori T; Sumino H; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
Eur Heart J; 2007 Apr; 28(8):989-95. PubMed ID: 17409109
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol therapy.
Toyama T; Hoshizaki H; Seki R; Isobe N; Adachi H; Naito S; Oshima S; Taniguchi K
J Nucl Med; 2003 Oct; 44(10):1604-11. PubMed ID: 14530474
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy--Clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography.
Yamazaki J; Muto H; Kabano T; Yamashina S; Nanjo S; Inoue A
Am Heart J; 2001 Apr; 141(4):645-52. PubMed ID: 11275933
[TBL] [Abstract][Full Text] [Related]
9. Use of iodine-123 metaiodobenzylguanidine myocardial imaging to predict the effectiveness of beta-blocker therapy in patients with dilated cardiomyopathy.
Fukuoka S; Hayashida K; Hirose Y; Shimotsu Y; Ishida Y; Kakuchi H; Eto T
Eur J Nucl Med; 1997 May; 24(5):523-9. PubMed ID: 9142733
[TBL] [Abstract][Full Text] [Related]
10. Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy.
Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
J Am Coll Cardiol; 2003 Feb; 41(4):574-81. PubMed ID: 12598068
[TBL] [Abstract][Full Text] [Related]
11. Spironolactone improves cardiac sympathetic nerve activity and symptoms in patients with congestive heart failure.
Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
J Nucl Med; 2002 Oct; 43(10):1279-85. PubMed ID: 12368364
[TBL] [Abstract][Full Text] [Related]
12. Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy: assessment by increase in myocardial 123I-metaiodobenzylguanidine uptake.
Lotze U; Kaepplinger S; Kober A; Richartz BM; Gottschild D; Figulla HR
J Nucl Med; 2001 Jan; 42(1):49-54. PubMed ID: 11197980
[TBL] [Abstract][Full Text] [Related]
13. Myocardial beta-adrenergic receptor density assessed by 11C-CGP12177 PET predicts improvement of cardiac function after carvedilol treatment in patients with idiopathic dilated cardiomyopathy.
Naya M; Tsukamoto T; Morita K; Katoh C; Nishijima K; Komatsu H; Yamada S; Kuge Y; Tamaki N; Tsutsui H
J Nucl Med; 2009 Feb; 50(2):220-5. PubMed ID: 19164238
[TBL] [Abstract][Full Text] [Related]
14. Low dose dobutamine stress echocardiography predicts the improvement of left ventricular systolic function in dilated cardiomyopathy.
Kitaoka H; Takata J; Yabe T; Hitomi N; Furuno T; Doi YL
Heart; 1999 May; 81(5):523-7. PubMed ID: 10212172
[TBL] [Abstract][Full Text] [Related]
15. Sympathetic nerve alterations assessed with 123I-MIBG in the failing human heart.
Merlet P; Pouillart F; Dubois-Randé JL; Delahaye N; Fumey R; Castaigne A; Syrota A
J Nucl Med; 1999 Feb; 40(2):224-31. PubMed ID: 10025827
[TBL] [Abstract][Full Text] [Related]
16. Relationship between evaluation by quantitative fatty acid myocardial scintigraphy and response to beta-blockade therapy in patients with dilated cardiomyopathy.
Ito T; Hoshida S; Nishino M; Aoi T; Egami Y; Takeda T; Kawabata M; Tanouchi J; Yamada Y; Kamada T
Eur J Nucl Med; 2001 Dec; 28(12):1811-6. PubMed ID: 11734920
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of therapy for dilated cardiomyopathy with heart failure by iodine-123 metaiodobenzylguanidine imaging: comparison with heart rate variability power spectral analysis].
Li S; Ikeda J; Takita T; Sekiguchi Y; Demachi J; Chikama H; Goto A; Shirato K
J Cardiol; 1998 Nov; 32(5):323-9. PubMed ID: 9864689
[TBL] [Abstract][Full Text] [Related]
18. Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study.
Agostini D; Belin A; Amar MH; Darlas Y; Hamon M; Grollier G; Potier JC; Bouvard G
J Nucl Med; 2000 May; 41(5):845-51. PubMed ID: 10809201
[TBL] [Abstract][Full Text] [Related]
19. Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy.
Waagstein F; Strömblad O; Andersson B; Böhm M; Darius M; Delius W; Goss F; Osterziel KJ; Sigmund M; Trenkwalder SP; Wahlqvist I
Eur J Heart Fail; 2003 Oct; 5(5):679-91. PubMed ID: 14607208
[TBL] [Abstract][Full Text] [Related]
20. Myocardial scintigraphy using iodine-123 15-(p-iodophenyl)-3-R, S-methylpentadecanoic acid predicts the response to beta-blocker therapy in patients with dilated cardiomyopathy but does not reflect therapeutic effect.
Yoshinaga K; Tahara M; Torii H; Akimoto M; Kihara K; Tei C
J Cardiol; 2000 May; 35(5):343-51. PubMed ID: 10834178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
